SLC12A3 and chronic kidney disease: Additionally, a recent publication to the NEJM stating that thiazides, which are NCC inhibitors, are successful in treating advanced CKD raises the possibility that NCC is responsible for this elevated salt sensitivity in CKD (Agarwal et al., 2021).